Corrales, NM, United States of America

Kenneth R Crandall

This inventor holds 1 USPTO granted patent. Top assignee: Accsys Technology, Incorporated. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth R Crandall. Retrieved from https://idiyas.com/inventor/kenneth-r-crandall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 96(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kenneth R. Crandall

Introduction

Kenneth R. Crandall is a notable inventor based in Corrales, New Mexico. He has made significant contributions to the field of proton-beam therapy, which is a cutting-edge treatment for cancer. His work has the potential to improve the effectiveness of cancer treatments and enhance patient outcomes.

Latest Patents

Kenneth R. Crandall holds a patent for a compact proton-beam therapy linac. This innovative device utilizes a linear, cascaded organization that includes a proton source, a radio-frequency-quadrupole (RFQ) linac, and a drift-tube linac (DTL). The design aims to produce an ultimate output proton-therapy beam that is efficient and effective for medical applications.

Career Highlights

Crandall is associated with Accsys Technology, Incorporated, where he continues to develop and refine his inventions. His work in the field of proton therapy has garnered attention for its potential to revolutionize cancer treatment methodologies.

Collaborations

Some of his notable coworkers include Robert W. Hamm and James M. Potter. Their collaborative efforts contribute to the advancement of technology in the medical field.

Conclusion

Kenneth R. Crandall's contributions to proton-beam therapy exemplify the impact of innovative thinking in medicine. His patent and ongoing work at Accsys Technology highlight the importance of advancements in cancer treatment technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…